9221 Reproductive Cancer Risk in Patients Treated with Denosumab Compared with Alendronate: A Population-based Cohort Study

Abstract Disclosure: S.K. Yahyavi: Research Investigator; Self; Principal investigator (PI) on an RCT with denosumab. C. Selmer: None. C. Torp-Pedersen: None. A. Juul: None. M. Blomberg Jensen: Other; Self; Holds two patents on the use of RANKL inhibitors to treat male infertility. BACKGROUND AND OB...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Endocrine Society Vol. 8; no. Supplement_1
Main Authors Yahyavi, Sam Kafai, Selmer, Christian, Torp-Pedersen, Christian, Juul, Anders, Jensen, Martin Blomberg
Format Journal Article
LanguageEnglish
Published US Oxford University Press 05.10.2024
Subjects
Abstract
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first